Bone development and inflammatory disease is regulated by AP-1 (Fos/Jun)

被引:118
作者
Wagner, E. F. [1 ]
机构
[1] Spanish Natl Canc Ctr CNIO, CNIO Canc Cell Biol Program, BBVA Fdn, E-28029 Madrid, Spain
关键词
JUN PROTEINS; SKIN-DISEASE; TRANSCRIPTION; ACTIVATOR; PSORIASIS; FOS;
D O I
10.1136/ard.2009.119396
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The Fos and Jun proteins are members of the AP-1 transcription factor complex, which is a central regulator for many cellular functions. This paper summarises the important functions of Fos proteins in bone development, with special emphasis on the Fos-related proteins Fra-1 and Fra-2. These factors determine the functions of osteoblasts and osteoclasts and regulate cytokine signalling during bone development. Likewise, the Jun proteins control the expression of cytokines and chemokines and are probably causally involved in inflammatory skin diseases such as psoriasis. Investigations into the molecular mechanisms responsible for skin inflammation have revealed that Jun proteins control cytokine expression, such as granulocyte colony-stimulating factor, IL-6 and tumour necrosis factor alpha by transcriptional and posttranscriptional pathways. Finally, the paper discusses the relevance of the Jun-dependent mouse model for psoriasis for preclinical studies in the field of anti-angiogenic therapies.
引用
收藏
页码:86 / 88
页数:3
相关论文
共 16 条
[1]   Function and regulation of AP-1 subunits in skin physiology and pathology [J].
Angel, P ;
Szabowski, A ;
Schorpp-Kistner, M .
ONCOGENE, 2001, 20 (19) :2413-2423
[2]   Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia [J].
Bozec, Aline ;
Bakiri, Latifa ;
Hoebertz, Astrid ;
Eferl, Robert ;
Schilling, Arndt F. ;
Komnenovic, Vukoslav ;
Scheuch, Harald ;
Priemel, Matthias ;
Stewart, Colin L. ;
Amling, Michael ;
Wagner, Erwin F. .
NATURE, 2008, 454 (7201) :221-U61
[3]   AP-1: A double-edged sword in tumorigenesis [J].
Eferl, R ;
Wagner, EF .
NATURE REVIEWS CANCER, 2003, 3 (11) :859-868
[4]   The Fos-related antigen Fra-1 is an activator of bone matrix formation [J].
Eferl, R ;
Hoebertz, A ;
Schilling, AF ;
Rath, M ;
Karreth, F ;
Kenner, L ;
Amling, M ;
Wagner, EF .
EMBO JOURNAL, 2004, 23 (14) :2789-2799
[5]   Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1 [J].
Eferl, Robert ;
Hasselblatt, Peter ;
Rath, Martina ;
Popper, Helmut ;
Zenz, Rainer ;
Komnenovic, Vukoslav ;
Idarraga, Maria-Helena ;
Kenner, Lukas ;
Wagner, Erwin F. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (30) :10525-10530
[6]   Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-l [J].
Jochum, W ;
David, JP ;
Elliott, C ;
Wutz, A ;
Plenk, H ;
Matsuo, K ;
Wagner, EF .
NATURE MEDICINE, 2000, 6 (09) :980-984
[7]   The AP1 transcription factor Fra2 is required for efficient cartilage development [J].
Karreth, F ;
Hoebertz, A ;
Scheuch, H ;
Eferl, R ;
Wagner, EF .
DEVELOPMENT, 2004, 131 (22) :5717-5725
[8]  
MEHIC D, J INVEST DERMATOL, V124, P212
[9]   Epidermal JunB represses G-CSF transcription and affects haematopoiesis and bone formation [J].
Meixner, Arabella ;
Zenz, Rainer ;
Schonthaler, Helia B. ;
Kenner, Lukas ;
Scheuch, Harald ;
Penninger, Josef M. ;
Wagner, Erwin F. .
NATURE CELL BIOLOGY, 2008, 10 (08) :1003-1011
[10]   Overexpression of ΔFosB transcription factor(s) increases bone formation and inhibits adipogenesis [J].
Sabatakos, G ;
Sims, NA ;
Chen, J ;
Aoki, K ;
Kelz, MB ;
Amling, M ;
Bouali, Y ;
Mukhopadhyay, K ;
Ford, K ;
Nestler, EJ ;
Baron, R .
NATURE MEDICINE, 2000, 6 (09) :985-990